Lavipharm is an integrated group engaged in the research, development, manufacturing, import, marketing and sales, distribution, and wholesaling of pharmaceutical and healthcare products in Greece, with a strong international activity. Since 1911, the Company has established a solid commercial position in Greece, while over the years it has evolved into a leading developer and manufacturer of drug delivery systems, mainly TTS, both locally and internationally.
Products from Lavipharm (2)
A latest generation nitroglycerin patch for the treatment of coronary artery disease and heart failure. Transdermal Drug Delivery Systems (TDDS) are one of the pharmaceutical technologies, in which Lavipharm is actively and successfully engaged. TDDSs are placed on the skin and allow specific drug subs...
A fentanyl transdermal delivery system, developed by Lavipharm's research laboratories in the USA and approved by the FDA, is a small, thin and easy to adhere patch for the management of chronic pain. It is designed to deliver the analgesic substance fentanyl safely and effectively through the skin. ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance